packageRolapitant

rolapitant

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Rolapitant is an antiemetic used to prevent nausea and vomiting associated with cancer treatment. It has been approved as a medicine, though its marketing authorisation in the European Union has been withdrawn.

Summary written by glm-5.3-flash from Wikidata Q76415423 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:rolapitant
ATC codes:A04AD14
DrugBank:DB09291
PubChem CID:10311306
ChEBI:90908
Wikidata:Q76415423
formula:C25H26F6N2O2
molar mass:500.483 g/mol (PubChem CID 10311306)
logP:4.4 (Drugs.Common 25.09, not verified)

Metabolites

M19M19516.482 g/mol (pubchem)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown

Contents

NameDescription
M19metabolite: M19